Ryman Healthcare Statistics

Total Valuation

Ryman Healthcare has a market cap or net worth of NZD 3.23 billion. The enterprise value is 5.84 billion.

Market Cap	3.23B
Enterprise Value	5.84B

Important Dates

The next estimated earnings date is Thursday, February 27, 2025.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Ryman Healthcare has 685.99 million shares outstanding. The number of shares has increased by 12.70% in one year.

Current Share Class	n/a
Shares Outstanding	685.99M
Shares Change (YoY)	+12.70%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.91%
Owned by Institutions (%)	56.21%
Float	652.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	20.37
PS Ratio	4.50
PB Ratio	0.75
P/TBV Ratio	0.77
P/FCF Ratio	8.42
P/OCF Ratio	n/a
PEG Ratio	1.40

Financial Ratio History

Enterprise Valuation

EV / Earnings	-66.43
EV / Sales	8.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	15.23

Financial Position

The company has a current ratio of 0.04, with a Debt / Equity ratio of 0.61.

Current Ratio	0.04
Quick Ratio	0.03
Debt / Equity	0.61
Debt / EBITDA	2,576.30
Debt / FCF	6.86
Interest Coverage	-0.28

Financial Efficiency

Return on equity (ROE) is -1.92% and return on invested capital (ROIC) is -0.27%.

Return on Equity (ROE)	-1.92%
Return on Assets (ROA)	-0.15%
Return on Capital (ROIC)	-0.27%
Revenue Per Employee	93,552
Profits Per Employee	-11,421
Employee Count	7,700
Asset Turnover	0.06
Inventory Turnover	137.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-20.17%
50-Day Moving Average	4.66
200-Day Moving Average	4.41
Relative Strength Index (RSI)	58.78
Average Volume (20 Days)	1,267,319

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ryman Healthcare had revenue of NZD 720.35 million and -87.94 million in losses. Loss per share was -0.13.

Revenue	720.35M
Gross Profit	17.10M
Operating Income	-30.40M
Pretax Income	-93.75M
Net Income	-87.94M
EBITDA	-3.02M
EBIT	-30.40M
Loss Per Share	-0.13

Full Income Statement

Balance Sheet

The company has 22.57 million in cash and 2.63 billion in debt, giving a net cash position of -2.61 billion or -3.81 per share.

Cash & Cash Equivalents	22.57M
Total Debt	2.63B
Net Cash	-2.61B
Net Cash Per Share	-3.81
Equity (Book Value)	4.30B
Book Value Per Share	6.27
Working Capital	-5.46B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 607.84 million and capital expenditures -224.24 million, giving a free cash flow of 383.60 million.

Operating Cash Flow	607.84M
Capital Expenditures	-224.24M
Free Cash Flow	383.60M
FCF Per Share	0.56

Full Cash Flow Statement

Margins

Gross margin is 2.37%, with operating and profit margins of -4.22% and -12.21%.

Gross Margin	2.37%
Operating Margin	-4.22%
Pretax Margin	-13.01%
Profit Margin	-12.21%
EBITDA Margin	-0.42%
EBIT Margin	-4.22%
FCF Margin	53.25%

Dividends & Yields

Ryman Healthcare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.70%
Shareholder Yield	-12.70%
Earnings Yield	-2.74%
FCF Yield	11.87%

Dividend Details

Stock Splits

The last stock split was on January 29, 2007. It was a forward split with a ratio of 5.

Last Split Date	Jan 29, 2007
Split Type	Forward
Split Ratio	5

Scores

Ryman Healthcare has an Altman Z-Score of 0.1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.1
Piotroski F-Score	n/a